MIT Technology Review November 28, 2025
Plus: how influential tech figures hope to influence US AI regulation
This is today’s edition of The Download, our weekday newsletter that provides a daily dose of what’s going on in the world of technology.
What we still don’t know about weight-loss drugs
Weight-loss drugs have been back in the news this week. First, we heard that Eli Lilly, the company behind Mounjaro and Zepbound, became the first healthcare company in the world to achieve a trillion-dollar valuation.
But we also learned that, disappointingly, GLP-1 drugs don’t seem to help people with Alzheimer’s disease. And that people who stop taking the drugs when they become pregnant can experience potentially dangerous levels of weight gain. On top of that, some researchers...
Today's Sponsors
Today's Sponsor